^
Association details:
Evidence:
Evidence Level:
Sensitive: D – Preclinical
New
Title:

Abstract 2890: IMGN151 - A next generation folate receptor alpha targeting antibody drug conjugate active against tumors with low, medium and high receptor expression

Published date:
05/15/2020
Excerpt:
With a novel biparatopic antibody and linker payload design, IMGN151 has shown potent antitumor activity against ovarian cancer models with a broad range of FRα expression…
DOI:
10.1158/1538-7445.AM2020-2890